Recently, reports have shown that platelet-derived CD40L stimulates B-cell activity by enhancing Ig production [113] and these circulating, stimulated B-cells are excreting anti-gpIIb/IIIa antibodies in ITP patients at increased levels [114]. Here, ITGA2B is linked to autoimmune thrombocytopenic purpura.